Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories, for a combined purchase price of around $55.5m.
Research: A Fulgent lab technician uses a multichannel pipette to dispense a reagent. El Monte-based genetic testing and clinical lab analysis company Fulgent Genetics Inc., which rode the Covid ...
TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ -- CooperSurgical ®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (FLGT), a technology-based company ...
The company posted an unexpected profit in its latest reported quarter. That was accompanied by a double-digit improvement in revenue. That morning, before market open, Fulgent unveiled its ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today ...
Today, we revisit diagnostic testing concern Fulgent Genetics, Inc., which is currently navigating through the "COVID-19 cliff". Revenue growth should return in FY2025, and the company is sitting on a ...
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback